Acadia Healthcare (NASDAQ:ACHC – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday.
Several other research firms have also recently issued reports on ACHC. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a report on Friday, September 20th. Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, October 1st. Barclays lowered their price target on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a report on Monday, September 30th. Deutsche Bank Aktiengesellschaft lifted their target price on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Finally, KeyCorp began coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, Acadia Healthcare has an average rating of “Moderate Buy” and an average price target of $86.67.
Read Our Latest Stock Analysis on ACHC
Acadia Healthcare Price Performance
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. During the same period in the prior year, the company posted $0.91 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, research analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Acadia Healthcare
Several large investors have recently modified their holdings of the stock. Blue Trust Inc. boosted its stake in Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after acquiring an additional 248 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Acadia Healthcare in the second quarter valued at approximately $59,000. Covestor Ltd boosted its holdings in shares of Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock valued at $72,000 after purchasing an additional 1,018 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in Acadia Healthcare during the 3rd quarter worth $86,000.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories
- Five stocks we like better than Acadia Healthcare
- 3 Healthcare Dividend Stocks to Buy
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Top-Performing Non-Leveraged ETFs This Year
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.